Pancreatic Cancer Research

ResearcherCarol Davila University of Medicine and PharmacyNo recent work listed

Traian Dumitraşcu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-5343-7180; OpenAlex author ID A5032468467. Sources: OpenAlex.

Their work

Papers
11 (first author 2, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
31
Papers, trials and grants by year

2012: 2 papers · 2013: none · 2014: none · 2015: 1 paper · 2016: none · 2017: none · 2018: 5 papers · 2019: none · 2020: 1 paper · 2021: none · 2022: 2 papers

Papers 11

  1. Pancreatico-Duodenectomy for Pancreatic Ductal Adenocarcinoma: from Artery-First Approaches toTRIANGLE Operation. Co-author DOI 10.21614/chirurgia.2771↗
  2. Using Molecular Subtyping of Pancreatic Ductal Adenocarcinoma for Multimodal Treatment Selection in Resectable Disease. First author DOI 10.21614/chirurgia.2772↗
  3. A Morphological and Immunohistochemical Study of the Tumoral and Inflammatory Cells in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1155/2020/6148286↗
  4. Outcomes After Distal Pancreatectomy with Celiac Axis Resection for Pancreatic Cancer: A Pan-European Retrospective Cohort Study. Co-author DOI 10.1245/s10434-018-6391-z↗
  5. Correction to: Outcomes After Distal Pancreatectomy with Celiac Axis Resection for Pancreatic Cancer: A Pan-European Retrospective Cohort Study. Co-author DOI 10.1245/s10434-018-6442-5↗
  6. What is the Value of Total Mesopancreas Excision in Pancreatic Ductal Adenocarcinoma? Current Evidence of the Literature. First author DOI 10.21614/chirurgia.113.3.335↗
  7. Is Hepatitis B Virus a Player in Pancreatic Cancer? Co-author DOI 10.21614/chirurgia.113.3.344↗
  8. One Hundred Pancreatectomies with Venous Resection for Pancreatic Adenocarcinoma. Co-author DOI 10.21614/chirurgia.113.3.363↗
  9. Impact of Hepatitis B Virus on Clinicopathological Features and Outcomes After Resection for Pancreatic Adenocarcinoma. Co-author PMID 26254417↗
  10. An exploratory study of inflammatory cytokines as prognostic biomarkers in patients with ductal pancreatic adenocarcinoma. Co-author DOI 10.1097/mpa.0b013e3182546e13↗
  11. Update in pancreatic cancer surgery - focus on total mesopancreas excision. Co-author PMID 23118831↗

Closest collaborators

The 25 strongest of 31 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Irinel Popescu · 10 shared papers, 2012–2022 · strength 1.14
  2. Simona Dima · 6 shared papers, 2012–2022 · strength 0.54
  3. Dan Gabriel Duda · 2 shared papers, 2012–2022 · strength 0.26
  4. Vladislav Braşoveanu · 3 shared papers, 2015–2020 · strength 0.23
  5. Pascal Pineau · 2 shared papers, 2015–2018 · strength 0.22
  6. Vlad Herlea · 3 shared papers, 2012–2020 · strength 0.18
  7. Helmut Frieß · 2 shared papers, 2018 · strength 0.10
  8. Matteo De Pastena · 2 shared papers, 2018 · strength 0.10
  9. Willem Niesen · 2 shared papers, 2018 · strength 0.10
  10. Manuela Cesaretti · 2 shared papers, 2018 · strength 0.10
  11. Sjors Klompmaker · 2 shared papers, 2018 · strength 0.10
  12. Frederik Christiaan Berrevoet · 2 shared papers, 2018 · strength 0.10
  13. Mustapha Adham · 2 shared papers, 2018 · strength 0.10
  14. Alain Sauvanet Sauvanet · 2 shared papers, 2018 · strength 0.10
  15. Julie Périnel · 2 shared papers, 2018 · strength 0.10
  16. Anastasios J. Karayiannakis · 2 shared papers, 2018 · strength 0.10
  17. Markus K. Diener · 2 shared papers, 2018 · strength 0.10
  18. Mickaël Lesurtel · 2 shared papers, 2018 · strength 0.10
  19. Geert Roeyen · 2 shared papers, 2018 · strength 0.10
  20. Robert Grützmann · 2 shared papers, 2018 · strength 0.10
  21. Ugo Boggi · 2 shared papers, 2018 · strength 0.10
  22. Marc G. Besselink · 2 shared papers, 2018 · strength 0.10
  23. Marco Del Chiaro · 2 shared papers, 2018 · strength 0.10
  24. Claudio Bassi · 2 shared papers, 2018 · strength 0.10
  25. Jony van Hilst · 2 shared papers, 2018 · strength 0.10

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.